Hosted on MSN11mon
Savara Inc. to Address Barclays Global Healthcare Conference on Rare Respiratory DiseasesThe drug is delivered via an investigational eFlow® Nebulizer System, developed by PARI Pharma GmbH. The management team at Savara brings a wealth of experience in rare respiratory diseases ...
MOLBREEVI is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH) specifically developed for inhalation of a large molecule. Our management team has significant experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback